Alimera Sciences' Iluvien Receives FDA Priority Review for the Treatment of Diabetic Macular Edema

Alimera has received Priority Review status by the FDA for Iluvien, its drug delivery system to treat diabetic macular edema.... [more]

View complete Press Release article